DNL-622

N/A

Report date: 2025/03/18 15:02:40

Base Information

Drug NameDNL-622
Drug Alias NameETV:Alpha-L-IduronidaseETV-IDUAETV:IDUADNL-622
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionAlpha-L-iduronidase replacements
TargetsAlpha-L-iduronidase
Therapy Area/IndicationsMucopolysaccharidosis I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A